HIPRA Introduces UNISTRAIN PRRS to European Swine Veterinarians10 June 2013
EU - In the framework of the European Symposium of Porcine Health Management 2013 (ESPHM), HIPRA presented UNISTRAIN® PRRS, the new effective alternative for the control of the most costly disease in pig production.
More than one hundred swine veterinarians from Spain, Germany, United Kingdom, Belgium, Holland, France, Italy, Poland, Portugal, Greece and Russia, attended the "UNISTRAIN® PRRS Meeting" that took place in the castle of Edinburgh, on 21 May.
A private visit to the Crown Jewels gave way to the introduction of the new vaccine, through a new format, where audiovisual media were the protagonists. The presentation began with the testimonials of veterinary experts and consultants of swine of international prestige, who gave their point of view regarding the present and future of PRRS. It continued with safety and efficacy tests conducted with UNISTRAIN® PRRS through the testimonial of the R&D HIPRA team, finally showing the process of production of vaccines in HIPRA, opening the doors of the company's facilities. The act was introduced by Isaac Rodríguez-Ballarà, Product Manager of UNISTRAIN® PRRS.
David Nogareda, President and CEO of the company, closed the event stressing the commitment to HIPRA becoming the Reference in Prevention in Animal Health.
Subsequently the attendees enjoyed a gala dinner that was enlivened by different shows.
This meeting is part of the launch campaign of UNISTRAIN® PRRS, which began in April and will last until the end of June in all countries of the European Union.
Find out more information on PRRS by clicking here.
ThePigSite News Desk